Sanofi (SNY) Stock Price, News & Analysis

Company Overview

Sanofi is a global healthcare company headquartered in France that develops, manufactures and markets prescription medicines and vaccines. Its portfolio serves patients across areas including immunology, rare diseases, rare blood disorders, neurology, oncology and inflammatory conditions, as well as other specialty-care and general-medicine categories.

The company is also a major vaccine producer through its vaccines business, which supplies products for diseases such as influenza, polio, pertussis, meningitis and dengue. Sanofi sells its medicines and vaccines in markets worldwide, serving healthcare providers, governments and patients across North America, Europe, Asia and other international regions.

Sanofi traces its origins to the establishment of Sanofi in 1973 and expanded through major industry combinations, including its 1999 merger with Synthélabo and its 2004 acquisition of Aventis. The company adopted the shorter Sanofi name in 2011. Paul Hudson has served as chief executive officer since 2019, leading the company’s focus on innovative medicines and vaccines.

Key Stats

• Today's Range: $42.34 to $42.77
• 50-Day Range: $42.40 to $46.02
• 52-Week Range: $40.89 to $52.68
• Volume: 2.24 million shs
• Average Volume: 3.40 million shs
• Market Capitalization: $102.99 billion
• P/E Ratio: 22.24
• Dividend Yield: 4.14%
• Price Target: $49.50
• Consensus Rating: Hold

Sanofi Stock Analysis - MarketRank™

Sanofi scored higher than 67% of companies evaluated by MarketBeat, and ranked 274th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.1 / 5
• Analyst Rating: Hold

Consensus Rating

Sanofi has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 2 strong buy ratings, 3 buy ratings, 10 hold ratings, and 1 sell rating.

Upside Potential

Sanofi has a consensus price target of $49.50, representing about 16.4% upside from its current price of $42.53.

Amount of Analyst Coverage

Sanofi has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.34%

Earnings Growth

Earnings for Sanofi are expected to grow by 4.34% in the coming year, from $5.07 to $5.29 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Sanofi is 22.26, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.92.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sanofi is 22.26, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.66.

Price to Earnings Growth Ratio

Sanofi has a PEG Ratio of 1.28. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Sanofi has a P/B Ratio of 1.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

0.34% of the float of Sanofi has been sold short.

Short Interest Ratio / Days to Cover

Sanofi has a short interest ratio ("days to cover") of 4.03.

Change versus previous month

Short interest in Sanofi has recently increased by 12.58%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Sanofi is a leading dividend payer. It pays a dividend yield of 4.16%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Sanofi does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sanofi is 92.15%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Sanofi will have a dividend payout ratio of 33.27% next year. This indicates that Sanofi will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.69

News Sentiment

Sanofi has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.80 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Sanofi this week, compared to 7 articles on an average week.

Search Interest

15 people have searched for SNY on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.

MarketBeat Follows

5 people have added Sanofi to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sanofi insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.00% of the stock of Sanofi is held by insiders.

Percentage Held by Institutions

14.03% of the stock of Sanofi is held by institutions.

Company Calendar

• Last Earnings: 7/30/2026
• Today: 9/18/2026
• Next Earnings (Estimated): 10/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:SNY
• CIK: 1121404
• Web: www.sanofi.com
• Phone: (315) 377-4000
• Fax: 33-1-53-77-43-03
• Employees: 74,846
• Year Founded: 1994

Price Target and Rating

• Average Price Target for Sanofi: $49.50
• High Price Target: $50.00
• Low Price Target: $49.00
• Potential Upside/Downside: +16.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.38
• Research Coverage: 16 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.91
• Trailing P/E Ratio: 22.24
• Forward P/E Ratio: 8.38
• P/E Growth: 1.28
• Net Income: $8.84 billion
• Net Margins: 8.66%
• Pretax Margin: 12.00%
• Return on Equity: 14.19%
• Return on Assets: 7.95%

Debt

• Debt-to-Equity Ratio: 0.21
• Current Ratio: 0.99
• Quick Ratio: 0.64

Sales & Book Value

• Annual Sales: $48.92 billion
• Price / Sales: 2.11
• Cash Flow: $7.04 per share
• Price / Cash Flow: 6.03
• Book Value: $33.27 per share
• Price / Book: 1.28

Miscellaneous

• Outstanding Shares: 2,424,425,000
• Free Float: 2,400,181,000
• Market Cap: $102.99 billion
• Optionable: Optionable
• Beta: 0.35